Accessibility Menu
Pediatrix Medical Group logo

Pediatrix Medical Group(NYSE) MD

Market Cap$2.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)+391%
5 Year-20%
1 Year+61%
1 Month+0%
Premium Feature
Moneyball Superscore
60/100
$26.41
+0.73%
+0.19Today
Pediatrix Medical Group last closing stock price
MetricPriceDate
Last closeUSD 26.222026-08-20
Pediatrix Medical Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.57%USD 26.372026-08-13
1 month+0.31%USD 26.142026-07-21
3 month+23.33%USD 21.262026-05-22
Year to date+22.58%USD 21.392025-12-31
1 year+61.16%USD 16.272025-08-20
3 year+76.57%USD 14.852023-08-21
5 year-20.21%USD 32.862021-08-20
Since inception+390.67%USD 5.341995-09-20

Pediatrix Medical Group Financials at a Glance

Market Cap

$2.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.95B

Net Income (TTM)

$174.81M

EPS (TTM)

$2.08

P/E Ratio

12.59

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$26.41

Volume

270,561.001

Open

$26.20

Previous Close

$26.22

Daily Range

$26.00 - $26.68

52-Week Range

$15.70 - $27.94

Estimated Earnings Date

Nov 2, 2026

MD: Motley Fool Moneyball Superscore

60

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pediatrix Medical Group

Pediatrix Medical Group cares for sick newborns and pregnant women. It manages hospital units for infants with medical complications. The company also treats children with heart and surgical needs.

Core Specialist Medical Services

  • Neonatal Care: Clinical services for premature or critically ill infants in hospital neonatal intensive care units (NICUs).
  • Maternal-Fetal Medicine: Specialist care for mothers and babies during high-risk or medically complicated pregnancies.
  • Pediatric Cardiology: Heart condition treatments for patients ranging from fetal development stages through adulthood.
  • Subspecialty Services: Physician expertise for pediatric intensive care, surgery, and ophthalmology departments.

Expanding the Clinical Footprint

  • Acquired several medical practices that contributed to revenue growth during the first half of 2026.
  • Renamed the business from MEDNAX in July 2022 to emphasize its focus on maternal and pediatric care.
  • Transitioned to a hybrid revenue cycle management model to improve billing and collection efficiency.
  • Refinanced credit facilities in February 2022 to include a $450.0 million revolving line of credit.

Operating a National Care Network

Pediatrix coordinates a network of approximately 2,700 physicians across 37 states and Puerto Rico as of February 2022. The group serves as a primary clinical partner for hospitals by providing specialized neonatal and maternal-fetal medical teams.

Performance by the Numbers

  • Net revenue was $487.8 million for the three months ended June 30, 2026, up 4.0% year over year.
  • Adjusted EBITDA hit $134.6 million for the six-month period ended June 30, 2026, up from $122.4 million in the prior year period.
  • Net income reached $69.4 million for the first half of 2026, up from $60.0 million in the same period of 2025.
  • Days sales outstanding, a measure of payment collection speed, dropped to 42.5 days by June 30, 2026.
  • Market capitalization reached $2.1 billion in the second quarter of 2026, up 66.7% year over year.

Evolution Into Specialty Care

Pediatrix has transitioned into a focused provider of specialized maternal and pediatric healthcare services. Its national clinician network and focus on high-acuity hospital care support its long-term operational stability.

AI Generated • Aug 4, 2026

Industry

Healthcare Providers and Services

Employees

6,575

CEO

Mark S. Ordan, MBA

Headquarters

Sunrise, FL 33323, US

MD Financials

Key Financial Metrics (TTM)

Gross Margin

25.95%

Operating Margin

11.60%

Net Income Margin

8.96%

Return on Equity

19.89%

Return on Capital

15.14%

Return on Assets

8.21%

Earnings Yield

7.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

81.25M

Volume

270.56K

Avg. Volume

806.68K

Financials (TTM)

Gross Profit

$506.14M

Operating Income

$226.23M

EBITDA

$267.04M

Operating Cash Flow

$247.21M

Capital Expenditure

-$18.25M

Free Cash Flow

$228.96M

Cash & ST Invst.

$404.20M

Total Debt

$619.96M

Pediatrix Medical Group Performance Analysis

Pediatrix Medical Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,972,021,0003.2%
20232023-12-31USD 1,994,640,0001.1%
20242024-12-31USD 2,012,919,0000.9%
20252025-12-31USD 1,913,849,000-4.9%
Pediatrix Medical Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-305.1%
Q42025-12-310.2%
Q12026-03-31-3.6%
Q22026-06-302.4%
Pediatrix Medical Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.79-48.3%
20232023-12-31USD -0.73N/A
20242024-12-31USD -1.1961.8%
20252025-12-31USD 1.94N/A
Pediatrix Medical Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3086.7%
Q42025-12-31-52.4%
Q12026-03-31-10.0%
Q22026-06-3036.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$487.78M

+4.0%

Gross Profit

$132.47M

+6.2%

Gross Margin

27.16%

N/A

Market Cap

$2.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$497.77K

N/A

Employees

4,280

N/A

Net Income

$39.84M

+1.5%

EBITDA

$57.45M

-17.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$404.20M

+16.0%

Total Debt

$619.96M

-4.6%

Accounts Receivable

$239.01M

-3.1%

Inventory

$0.00

N/A

Long Term Debt

$421.54M

-31.3%

Short Term Debt

$198.42M

+455.3%

Return on Assets

8.21%

N/A

Return on Invested Capital

13.89%

N/A

Free Cash Flow

$123.94M

-6.6%

Operating Cash Flow

$125.32M

-8.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SEMSelect Medical Holdings Corporation
$16.51-0.09%
ADUSAddus HomeCare Corporation
$121.31+0.63%
ASTHAstrana Health, Inc.
$38.67-0.18%
GRDNGuardian Pharmacy Services, Inc.
$37.48+0.07%

Trending Stocks

Symbol / CompanyPricePrice Chg
IBITiShares Bitcoin Trust
$43.77+0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.82+0.11%
BITOProShares Trust - ProShares Bitcoin ETF
$10.44+0.06%
MARAMara Holdings
$11.13-0.00%

Questions About MD

What is the current price of Pediatrix Medical Group?

Pediatrix Medical Group is trading at $26.43 per share.

What is the 52-week range for Pediatrix Medical Group?

Over the past 52 weeks, Pediatrix Medical Group has traded between $15.70 and $27.94.

How much debt does Pediatrix Medical Group have?

As of the most recent reporting period, Pediatrix Medical Group reported total debt of $619.96M.

How much cash does Pediatrix Medical Group have on hand?

Pediatrix Medical Group reported $288.88M in cash and cash equivalents in its most recent financial results.

What is Pediatrix Medical Group’s dividend yield?

Pediatrix Medical Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.